A new study by scientists at ARIAD provides an overview of the design of small molecule drugs to treat drug-resistant leukemia
activity, which may be useful in treating certain diseases.For more information about ARIAD can be found on the web at ARIAD.This press release contains forward-looking statements, including statements regarding the potential utility of AP24534 and the timing of the regulations. Forward-looking statements are based on managements expectations and are subject to certain factors, risks and uncertainties that could cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, costs associated with our research, development, production and other activities, the conduct and results of preclinical and clinical studies of our product
candidates, difficulties or delays in obtaining regulatory approvals marketing of products derived from our development efforts, our reliance on strategic partners and licensees and other key elements for successful development of production and marketing of products, the adequacy of our capital resources and availability of additional funding, patent protection and third party intellectual property claims related to our product candidates and any partner, the timing, scope, cost and outcome of legal proceedings and the patent office with respect to our portfolio of NF- kB patent, the potential acquisition of other strategic transaction or with respect to minority shareholders in the subsidiary to 80%, ARIAD Gene Therapeutics, Inc., The future capital needs, key employees,
markets, economic conditions, prices, reimbursement rates, competition and other factors disclosed in public filings with the Companys Securities and Exchange Commission are listed. The information in this document estimates that the current at the time of initial issue. The Company does not intend the forward-looking statements after the date of this updated document to conform these statements to actual results Pages: 1 2 [3] 4